Evidence map›Paper›PMID 34769499›Full record

ArticleInternational journal of molecular sciences2021

Insights into Intra-Tumoral Heterogeneity: Transcriptional Profiling of Chemoresistant MPM Cell Subpopulations Reveals Involvement of NFkB and DNA Repair Pathways and Contributes a Prognostic Signature.

Mario Cioce, Andrea Sacconi, Harvey I Pass, Claudia Canino, Sabrina Strano, Giovanni Blandino, Vito Michele Fazio

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Mario CioceDepartment of Medicine, R.U. in Molecular Medicine and Biotechnology, University Campus Bio-Medico of Rome, 00128 Rome, Italy.ORCID 0000-0001-8129-6664
Andrea SacconiClinical Trial Center, Biostatistics and Bioinformatics Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Harvey I PassDivision of General Thoracic Surgery, Department of Cardiothoracic Surgery, New York University Langone Medical Center, New York, NY 10016, USA.
Claudia CaninoRadiation Oncology Unit, UPMC Hillmann Cancer Center, San Pietro Hospital FBF, 00189 Rome, Italy.
Sabrina StranoSmall Animal Facility Unit, Department of Research, Diagnosis and Innovative Technologies, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.ORCID 0000-0002-6341-4230
Giovanni BlandinoOncogenomic and Epigenetic Unit, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
Vito Michele FazioDepartment of Medicine, R.U. in Molecular Medicine and Biotechnology, University Campus Bio-Medico of Rome, 00128 Rome, Italy.
Università Campus Bio-Medico · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITNYU Langone Health · USOspedale San Pietro Fatebenefratelli · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemoresistance is a hallmark of malignant pleural mesothelioma (MPM) management and the expression of ALDH1A3 is responsible for the survival and activity of MPM chemoresistant cell subpopulations (ALDH

Indexed as

DNA RepairAldehyde OxidoreductasesCell Line, TumorClonal EvolutionDrug Resistance, NeoplasmFlow CytometryHumansMesothelioma, MalignantNF-kappa BPrognosisSurvival Ratealdehyde dehydrogenase (NAD(P)+)Aldehyde OxidoreductasesNF-kappa BALDHbuteinCancer Stem Cell (CSC)chemoresistanceDNA repairgene expressionintra-tumoral heterogeneity (ITH)mesotheliomaNFkB

Identifiers

PMID34769499
PMCPMC8585077
OpenAlexW3213769415

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.